Half Year 2025 Dis-Chem Pharmacies Ltd Earnings Call Transcript

Oct 25, 2024 / 08:00AM GMT
Rui Morais – Dis-Chem Pharmacies Ltd – Chief Executive Officer

Good morning, everyone, and welcome to Dis-Chem Pharmacies results for 2024. I will start off by summarizing the group highlights for the financial year-ended 2024. Before I go into each of the highlights, I would just personally like to thank my immediate team and the greater group for the support as I’ve started my tenure as CEO. I think fundamentally, some of the strategic objectives have been supported, and we can see them playing out in some of the highlights that I’ll talk to and in the residual presentation. If we look at group, group revenue increased by 11.1% to ZAR36.3 billion.

The second half, as I mentioned earlier, delivered profit before tax growth of 22%, fundamentally a function of operational positive leverage as we managed to control cost well. And we’ll talk a lot about cost control as we go through the presentation, and we saw increased revenue growth in the second half of the year. That delivered after what was a relatively poor first half that delivered earnings per share, excluding the property gain in the